drugset

drugset / Trial / NCT01342744

Metformin in Postmenopausal Women With Metabolic Syndrome

NCT01342744 ↗

Phase 4 Unknown 40 enrolled Mahidol University

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effects of metformin on cardiovascular risk factors in postmenopausal women with metabolic syndrome.

Timeline

Start: 2011-04
Primary completion: 2012-03
Completion: 2012-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Metformin	Small molecule	850 mg	Oral

Indications